FDA Inspection 1245609 — American Red Cross Blood Services Southwest Region

American Red Cross Blood Services Southwest Region — FEI 3006805687

The FDA completed an inspection of American Red Cross Blood Services Southwest Region on July 11, 2024 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)